Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

938 - MiR-449a suppresses endometrial cancer invasion and metastasis by targeting NDRG1

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Presenters

Lihua Qiu

Citation

Annals of Oncology (2018) 29 (suppl_8): viii1-viii13. 10.1093/annonc/mdy268

Authors

L. Qiu

Author affiliations

  • Department Of Obstetrics And Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 200127 - Shanghai/CN
More

Resources

Abstract 938

Background

Endometrial cancer (EC) is the most common gynecologic malignancy in western counties. Generally, a five-year survival of patients with localized disease remains at approximately 96% and this rate drops to 67% and 17% for the patients suffering from regional and distant metastasis, respectively. Therefore, an improved understanding of the molecular mechanisms in metastasis of endometrial cancer has the potential to significantly impact the outcomes for this disease. Studies has outlined the essential roles for miR-449a in regulating pathogenesis of cancers. A number of reports have identified the role of microRNAs in EC, but little is known about miR-449a in it.

Methods

FISH was used to detect the expression of miR-449a in the 55 tissues and IHC was performed to measure the NDRG1 expression in the above samples. The alterations of NDRG1 gene were analyzed by cBioPortal for Cancer Genomics online. The human EC cell lines were cultured in DMEM/F12 medium supplemented with 10% fetal bovine serum and Penicillin/Streptomycin in a humid atmosphere incubator with 5% CO2 at 37 °C. The expression of miR-449a and NDRG1 were assayed by quantitative real time-PCR Wound healing assay, migration and invasion assays were performed to detect the ability of migration and invasion in EC cells. NDRG1 and PTEN/AKT pathway were detected by immunoblotting.

Results

In this study, our analysis found that miR-449a expression is inversely correlated with the stage of endometrial cancer. Overexpression of miR-449a in human EC cells alleviated cell invasion and metastasis in vitro. Conversely, miR-449a knock-down promoted migration and invasion of EC cells. Moreover, we identified N-myc Downstream-Regulated Gene 1 (NDRG1) as a direct and functional target gene of miR-449a in EC cells, and the expression NDRG1 in 55 endometrial cancer specimens were inversely correlated with that of miR-449a. In addition to this, further studies show that down-regulation of NDRG1 inhibited migration and invasion of EC cells through PTEN/AKT pathway.

Conclusions

miR-449a suppresses metastasis of EC cells by directly targeting NDRG1 gene and activation of miR-449a may represent an effective therapeutic strategy in endometrial cancer.

Clinical trial identification

Legal entity responsible for the study

Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai JiaoTong University, China.

Funding

National Natural Science Foundation of China (81272884).

Editorial Acknowledgement

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings